Home   >  
Protease/Metabolic Enzyme
  • Microbiology/Virology
  >  
Integrase
  • HIV
  >   Raltegravir potassium
Raltegravir potassium Chemical Structure

Raltegravir potassium

Cat. No. :BCP01757CAS No. :871038-72-1Purity:99%
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Information
  • Introduction
  • Quality Control
Synonyms MK-0518;Raltegravir Potassium Salt;Raltegravir
CAS Number 871038-72-1
Purity 99%
M. Wt 444.41
Formula C20H20FKN6O5
Storage Store at 4-8°C
PFV IN carrying the S217H substitution is 10-fold less susceptible to Raltegravir with IC50 of 900 nM. PFV IN displays 10% of WT activity and is inhibited by Raltegravir with an IC50 of 200 nM, indicating a ~twofold decrease in susceptibility to the IN strand transfer inhibitor (INSTI) compared with WT IN. S217Q PFV IN is as sensitive to Raltegravir as the WT enzyme. Raltegravir is metabolized by glucuronidation, not hepatically. Raltegravir has potent in vitro activity against HIV-1, with a 95% inhibitory concentration of 31?0 nM, in human T lymphoid cell cultures. Raltegravir is also active against HIV-2 when Raltegravir is tested in CEMx174 cells, with an IC95 of 6 nM. Raltegravir metabolism occurs primarily through glucuronidation. Drugs that are strong inducers of the glucuronidation enzyme, UGT1A1, significantly reduce Raltegravir concentrations and should not be used. Raltegravir exhibits weak inhibitory effects on hepatic cytochrome P450 activity. Raltegravir does not induce CY

Tags:Raltegravir potassium supplier,Raltegravir potassium purchase,Raltegravir potassium manufacturer,Raltegravir potassium distributor,Raltegravir potassium cost,Raltegravir potassium buy,Raltegravir potassium for sale

0086-13720134139
福建36选7奖金 亿客隆 老k棋牌手机版app下载 湖北麻将二条又叫什么 丫丫陕西麻将下载 六台宝典直播开奖下载 ewin456棋牌手机版下载 免费下载南昌麻将 腾讯麻将血流成河怎么玩 11选5中奖号码走势图 江西快三官网下载 二分时时彩全天计划 波克棋牌老版本下载 全民麻将游戏 武汉晃晃麻将 篮网锁定季后赛 亿客隆彩票首页